Lv0
0 积分 2026-01-06 加入
Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
16小时前
待确认
Ensifentrine: First Approval
28天前
已完结
Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease
1个月前
已完结
Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease
1个月前
已完结
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
2个月前
已完结
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
3个月前
已完结
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
3个月前
已完结
An enhanced mucus-penetrating miRNA delivery system for effective inhibition of bleomycin-induced pulmonary fibrosis in mice
4个月前
已完结
皖公网安备34019202002308
